BridgeMD
New treatment option for Lung Cancer
Official title Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
ClinicalTrials.gov ID: NCT06420206
What this study is testing
- What it's testing
- To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment
- Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative...
- Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
- Participant has the ability to speak and write in English
- Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent
You likely can't join if
- Participant is already enrolled in hospice
- Participant is comatose
- Participant has severe intellectual disability
- Participant has a history of dementia documented in the medical records
- Participant has baseline communication barriers such as aphasia or deafness
- Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival
See the full eligibility criteria
- Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment
- Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available.
- Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
- Participant has the ability to speak and write in English
- Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent
- Participant is already enrolled in hospice
- Participant is comatose
- Participant has severe intellectual disability
- Participant has a history of dementia documented in the medical records
- Participant has baseline communication barriers such as aphasia or deafness
- Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival
- Participant is 18 years or older, currently cared for by pediatrics service
- Pregnant women
- Prisoners
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.